Avior Wealth Management LLC Lowers Position in ARK Genomic Revolution ETF (BATS:ARKG)

Avior Wealth Management LLC trimmed its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 36.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,283 shares of the company’s stock after selling 9,835 shares during the quarter. Avior Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $567,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Operose Advisors LLC purchased a new position in ARK Genomic Revolution ETF during the third quarter worth approximately $25,000. Stephens Consulting LLC acquired a new stake in ARK Genomic Revolution ETF in the 3rd quarter valued at $28,000. Allworth Financial LP increased its holdings in ARK Genomic Revolution ETF by 65.3% in the 3rd quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock worth $40,000 after acquiring an additional 563 shares in the last quarter. High Net Worth Advisory Group LLC raised its position in ARK Genomic Revolution ETF by 80.9% during the first quarter. High Net Worth Advisory Group LLC now owns 1,118 shares of the company’s stock worth $51,000 after acquiring an additional 500 shares during the period. Finally, BKM Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF during the fourth quarter worth $78,000.

ARK Genomic Revolution ETF Trading Down 0.1 %

Shares of BATS ARKG opened at $23.55 on Friday. The firm has a 50-day moving average of $28.95 and a 200-day moving average of $28.46.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.